Background/Objectives Patients commonly present with a mix of intractable shoulder pain, persistent impingement/loss of shoulder motion, neck pain, headaches, and distal neuropathy. These patients are notoriously resistant to surgical and non-surgical treatments. Previously we proposed the Human Disharmony Loop (HDL) as a model that anatomically explains these symptoms and diagnostically predicts successful response to surgical intervention. The purpose of this study is to validate this model via retrospective chart review. We hypothesized that pectoralis minor release would reliably decrease pain and occipital headaches and increase shoulder motion for patients diagnosed with the HDL.

Methods Patients diagnosed with the HDL and treated with pectoralis minor release at two separate institutions with at least 6-month follow-up were included. Diagnosis was based on explicit anatomic and symptomatic criteria: coracoid tenderness, scapular protraction, and at least one end symptom. Neuropathy was tested using the scratch-collapse test. Outcomes included pain scores, clinical neuropathic lesions, rotator cuff impingement signs, shoulder range of motion, and complications.

Results 115 patients were included. Average age was 48. 37% were male. 89% of patients who received a preoperative subcoracoid injection reported a significant decrease in presenting symptoms. 6 months after PM release, median VAS pain scores decreased from 8 to 2. Occipital headaches decreased from 66% to 6%. Rotator cuff impingement decreased from 87% to 10%. Median shoulder abduction increased from 90 to 180 degrees. Neuropathy decreased at the following locations: scalenes 57 to 2%, suprascapular 51 to 0%, quadrilateral 81 to 5%, radial 60 to 11%, cubital 31 to 25%, carpal 53 to 25%. 25% of patients required secondary distal neurolysis. Complications remained low at 3% (3 seroma, 1 wound dehiscence).

Conclusions Patients diagnosed with the Human Disharmony Loop exhibit a dramatic clinical improvement following pectoralis minor release. A medial coracoid pectoralis minor block injection can aid in diagnosis but does not rule-out the syndrome. Patients showed significant reductions in shoulder pain, headaches, concomitant neuropathic lesions and improved shoulder range of motion. Patients should be counseled that some may need secondary neurolysis for residual neuropathy.

The authors have declared no competing interest.

This study did not receive any funding

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

St. Josephs Medical Center Research and Quality (RAQ) Committee gave ethical approval for this work. St. Lukes Health System IRB gave ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All data produced in the study are available upon reasonable request to the authors